Drug Type Antibody drug conjugate (ADC) |
Synonyms GO 3C7, GO-3C7 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Go Therapeutics, Inc.Startup |
Active Organization Go Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Adenocarcinoma | Preclinical | US | Go Therapeutics, Inc.Startup | - |
Head and Neck Neoplasms | Preclinical | US | Go Therapeutics, Inc.Startup | - |
Prostatic Cancer | Preclinical | US | Go Therapeutics, Inc.Startup | - |
Uterine Neoplasms | Preclinical | US | Go Therapeutics, Inc.Startup | - |